Aortic stenosis and transthyretin cardiac amyloidosis: The chicken or the egg?

European Heart Journal

Volumn 37, Issue 47, 2016, Pages 3525-3531

  Galat, Arnault ^a,b,c,d,e   Guellich, Aziz ^a,b,c,d,e   Bodez, Diane ^a,b,c,d,e   Slama, Michel ^f   Dijos, Marina ^g   Zeitoun, David Messika ^h   Milleron, Olivier ^h   Attias, David ⁱ   Dubois Randé, Jean Luc ^a,b,c,d,e   Mohty, Dania ^j   Audureau, Etienne ^a,b,c,d,e   Teiger, Emmanuel ^a,b,c,d,e   Rosso, Jean ^a,b,c   Monin, Jean Luc ^a,b,c,d,e   Damy, Thibaud ^a,b,c,d,e  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b Mondor Amyloidosis Network   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d INSERM U955   (France)

^e Henri Mondor Teaching Hospital   (France)

^f HÔPITAL ANTOINE BÉCLÈRE   (France)

^g BORDEAUX UNIVERSITY HOSPITAL   (France)

^h BICHAT HOSPITAL   (France)

ⁱ CENTRE CARDIOLOGIQUE DU NORD   (France)

^j DUPUYTREN UNIVERSITY HOSPITAL   (France)

more..

Author keywords

Aortic stenosis; Cardiac amyloidosis; Low flow low gradient; Transthyretin

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BRAIN NATRIURETIC PEPTIDE; PREALBUMIN; TROPONIN; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

AGED; AORTA STENOSIS; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; CARPAL TUNNEL SYNDROME; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENETIC SCREENING; HEART AMYLOIDOSIS; HEART EJECTION FRACTION; HEART VALVE REPLACEMENT; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INTERVENTRICULAR SEPTUM; MALE; MULTICENTER STUDY; MUSCLE THICKNESS; MUTATION; NEW YORK HEART ASSOCIATION CLASS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCINTIGRAPHY; TISSUE SECTION; TRANSCATHETER AORTIC VALVE IMPLANTATION; VERY ELDERLY; WILD TYPE; AORTIC VALVE STENOSIS; FAMILIAL AMYLOID POLYNEUROPATHY; HEART STROKE VOLUME; TREATMENT OUTCOME;

AGED; AMYLOID NEUROPATHIES, FAMILIAL; AORTIC VALVE STENOSIS; FEMALE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREALBUMIN; STROKE VOLUME; TREATMENT OUTCOME;

EID: 84991919031     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehw033     Document Type: Article

References (19)

1. Dumesnil JG, Pibarot P, Carabello B. Paradoxical low flow and/or low gradient severe aortic stenosis despite preserved left ventricular ejection fraction: implications for diagnosis and treatment. Eur Heart J 2010;31:281-289.
2. Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med 2003;349: 583-596.
3. Cornwell GG III, Murdoch WL, Kyle RA,Westermark P, Pitkanen P. Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med 1983;75:618-623.
4. Damy T, Judge DP, Kristen AV, Berthet K, Li H, Aarts J. Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Metand non-Val122Ile hereditary transthyretin amyloidosis. J Cardiovasc Transl Res 2015;8:117-127.
5. Rapezzi C, Merlini G, Quarta CC, Riva L, Longhi S, Leone O, Salvi F, Ciliberti P, Pastorelli F, Biagini E, Coccolo F, Cooke RM, Bacchi-Reggiani L, Sangiorgi D, Ferlini A, Cavo M, Zamagni E, Fonte ML, Palladini G, Salinaro F, Musca F, Obici L, Branzi A, Perlini S. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation 2009;120:1203-1212.
6. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC), European Association for Cardio-Thoracic Surgery (EACTS), Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012;33:2451-2496.
7. Zhao L, Buxbaum JN, Reixach N. Age-related oxidative modifications of transthyretin modulate its amyloidogenicity. Biochemistry 2013;52:1913-1926.
8. Henderson BC, Tyagi N, Ovechkin A, Kartha GK, Moshal KS, Tyagi SC. Oxidative remodeling in pressure overload induced chronic heart failure. Eur J Heart Fail 2007; 9:450-457.
9. Park JY, Ryu SK, Choi JW, Ho KM, Jun JH, Rha SW, Park SM, Kim HJ, Choi BG, Noh YK, Kim S. Association of inflammation, myocardial fibrosis and cardiac remodelling in patients with mild aortic stenosis as assessed by biomarkers and echocardiography. Clin Exp Pharmacol Physiol 2014;41:185-191.
10. Phelan D, Collier P, Thavendiranathan P, Popovic ZB, Hanna M, Plana JC, Marwick TH, Thomas JD. Relative apical sparing of longitudinal strain using twodimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart 2012;98:1442-1448.
11. Weidemann F, Herrmann S, Stork S, Niemann M, Frantz S, Lange V, Beer M, Gattenlohner S, Voelker W, Ertl G, Strotmann JM. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation 2009;120:577-584.
12. Allen RD, Edwards WD, Tazelaar HD, Danielson GK. Surgical pathology of subaortic septal myectomy not associated with hypertrophic cardiomyopathy: A study of 98 cases (1996-2000). Cardiovasc Pathol 2003;12:207-215.
13. Kristen AV, Schnabel PA, Winter B, Helmke BM, Longerich T, Hardt S, Koch A, Sack FU, Katus HA, Linke RP, Dengler TJ. High prevalence of amyloid in 150 surgically removed heart valves-A comparison of histological and clinical data reveals a correlation to atheroinflammatory conditions. Cardiovasc Pathol 2010;19:228-235.
14. Fitzmaurice GJ, Wishart V, Graham AN. An unexpected mortality following cardiac surgery: A post-mortem diagnosis of cardiac amyloidosis. Gen Thorac Cardiovasc Surg 2013;61:417-421.
15. Kotani N, Hashimoto H, Muraoka M, Kabara S, Okawa H, Matsuki A. Fatal perioperative myocardial infarction in four patients with cardiac amyloidosis. Anesthesiology 2000;92:873-875.
16. Monticelli FC, Kunz SN, Keller T, Bleiziffer S. Cardiac amyloidosis as a potential risk factor for transapical transcatheter aortic valve implantation. J Card Surg 2014;29: 623-624.
17. Moreno R, Dobarro D, Lopez de Sa E, Prieto M, Morales C, Calvo Orbe L, Moreno-Gomez I, Filgueiras D, Sanchez-Recalde A, Galeote G, Jimenez-Valero S, Lopez-Sendon JL. Cause of complete atrioventricular block after percutaneous aortic valve implantation: insights from a necropsy study. Circulation 2009;120: e29-e30.
18. Nietlispach F, Webb JG, Ye J, Cheung A, Lichtenstein SV, Carere RG, Gurvitch R, Thompson CR, Ostry AJ, Matzke L, Allard MF. Pathology of transcatheter valve therapy. JACC Cardiovasc Interv 2012;5:582-590.
19. Galat A, Rosso J, Guellich A, Van Der Gucht A, Rappeneau S, Bodez D, Guendouz S, Tissot CM, Hittinger L, Dubois-Rande JL, Plante-Bordeneuve V, Itti E, Meignan M, Damy T. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis. Amyloid : The international journal of experimental and clinical investigation. The official journal of the International Society of Amyloidosis 2015;22:210-220.